Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

A. J.J. Ijsselmuiden; P. W. Serruys; A. Scholte; F. Weber; C. A. Nienaber; Michael P. Savage; Francesco Burzotta

doi:10.1016/S1361-2611(03)00071-X

Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

A. J.J. Ijsselmuiden
, P. W. Serruys
, A. Scholte
, F. Weber
, C. A. Nienaber
, Michael P. Savage
, Francesco Burzotta

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Short survey › peer-review

Original language	English
Pages (from-to)	138-140
Number of pages	3
Journal	Evidence-based Cardiovascular Medicine
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/S1361-2611(03)00071-X
Publication status	Published - Sep 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1361-2611(03)00071-X

Cite this

@article{c5b47a7130754e34bc83570e33ff3863,

title = "Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation",

author = "Ijsselmuiden, \{A. J.J.\} and Serruys, \{P. W.\} and A. Scholte and F. Weber and Nienaber, \{C. A.\} and Savage, \{Michael P.\} and Francesco Burzotta",

year = "2003",

month = sep,

doi = "10.1016/S1361-2611(03)00071-X",

language = "English",

volume = "7",

pages = "138--140",

journal = "Evidence-based Cardiovascular Medicine",

issn = "1361-2611",

publisher = "Churchill Livingstone",

number = "3",

}

TY - JOUR

T1 - Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

AU - Ijsselmuiden, A. J.J.

AU - Serruys, P. W.

AU - Scholte, A.

AU - Weber, F.

AU - Nienaber, C. A.

AU - Savage, Michael P.

AU - Burzotta, Francesco

PY - 2003/9

Y1 - 2003/9

UR - https://www.scopus.com/pages/publications/3042793893

U2 - 10.1016/S1361-2611(03)00071-X

DO - 10.1016/S1361-2611(03)00071-X

M3 - Short survey

AN - SCOPUS:3042793893

SN - 1361-2611

VL - 7

SP - 138

EP - 140

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

IS - 3

ER -

Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

UN SDGs

Access to Document

Other files and links

Cite this